ACTON, MASSACHUSETTS, June 6, 2008 - Howard L. Levine, Ph.D., President, and Susan Dana Jones, Ph.D., Vice President and Senior Consultant, of BioProcess Technology Consultants will be featured speakers at the 2008 BIO International Convention, June 17-20, in San Diego, California.
Dr. Levine and Dr. Jones will both speak at BioProcess International’s BioProcess Product Focus Zone. The BioProcess Product Focus Zone, which features industry experts presenting the latest information about developing processes and products, will be held at Theater Booth #2438 in the BIO Exhibition Hall. Dr. Jones is on the editorial board of BioProcess International.
Dr. Levine’s presentation at 3:45 PM on Tuesday, June 17, will be “Efficient Project Management of Biopharmaceutical Development: Ensuring On-Time and Compliant Development Programs.” He will present project-management tools to help identify critical path items, ensure proper allocation of resources, and orchestrate the interplay and dependencies of wide-ranging CMC activities with preclinical and clinical activities to maximize the probability of successful product development.
Dr. Jones will speak at 3:30 PM on Thursday, June 19, on “Challenges in Scaling Up Newly Developed Microbial Manufacturing Processes,” and will describe an approach to streamlined development and scale-up of a microbial manufacturing process developed at small scale in an E. coli production host. The parameters for scaled-up production were based on multiple process demonstration runs at smaller scale. Fermentation scale-up directly from laboratory scale to the 1,000-L scale was seamless in most parameters because of a wealth of information obtained at the small scale. Dr. Jones will review and discuss some operations that did not transfer perfectly in order to identify small-scale activities and approaches that can increase the success rate of scale-up.
Dr. Levine will also be featured in a live podcast at 2:15 PM on Thursday, June 19, on “Trends in the Development of Fc-Fusion Proteins.” He will give an overview of this increasingly important class of biopharmaceutical products and compare and contrast the development and manufacturing requirements and costs of these products with conventional monoclonal antibodies.The podcast interview will be conducted in the Lobby outside Exhibit Hall A.
Further details on the presentations and podcast may be found at the BIO conference website at www.bio2008.org.
About BioProcess Technology Consultants, Inc.
Founded in 1994, BioProcess Technology Consultants provides a full range of strategic, technical, business, and regulatory assistance to pharmaceutical and biotechnology companies in the development and commercialization of new biopharmaceutical products. The company specializes in helping clients to develop manufacturing processes and strategies and assists in developing product discovery and process development programs that help speed products from clone to commercial.® BioProcess Technology Consultants also helps investors make informed decisions by providing technical and business evaluations of new products and technologies and product discovery, development, and commercialization plans of potential investments and existing portfolio companies. For more about BioProcess Technology Consultants, visit www.bioprocessconsultants.com
